Morgan Stanley’s Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share ZGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-573
Closed -$1.19K 7945
2022
Q4
$1.19K Hold
573
﹤0.01% 7448
2022
Q3
$1K Hold
573
﹤0.01% 7655
2022
Q2
$1K Sell
573
-100
-15% -$181 ﹤0.01% 7746
2022
Q1
$2K Hold
673
﹤0.01% 7797
2021
Q4
$1K Buy
+673
New +$1.39K ﹤0.01% 7925

Morgan Stanley's ZGN.WS Position: Q1 2023 in Review

Morgan Stanley sold out of Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (ZGN.WS) in Q1 2023, closing a stake of 573 shares — an estimated $1.19K sold.

Morgan Stanley first reported a position in ZGN.WS in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q1 2022. 0 funds tracked by Wall St. Rank hold ZGN.WS as of Q1 2023.

  • Morgan Stanley reported no remaining Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 573 Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.19K.
  • Morgan Stanley first reported a position in Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
  • Morgan Stanley's Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share position peaked at $2K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.